|
2-Furanacetaldehyde, 5-[(4E,6E,10Z,12E)-13-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-1,3,5,9,11-pentamethyl-2-oxo-4,6,10,12-tridecatetraenyl]tetrahydro-2,4-dimethyl- (9CI) Suppliers list
|
| Company Name: |
TargetMol |
| Tel: |
400-821-0310 15002144251 |
| Email: |
xuexiang.shao@tsbiochem.com |
|
| | 2-Furanacetaldehyde, 5-[(4E,6E,10Z,12E)-13-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-1,3,5,9,11-pentamethyl-2-oxo-4,6,10,12-tridecatetraenyl]tetrahydro-2,4-dimethyl- (9CI) Basic information |
| Product Name: | 2-Furanacetaldehyde, 5-[(4E,6E,10Z,12E)-13-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-1,3,5,9,11-pentamethyl-2-oxo-4,6,10,12-tridecatetraenyl]tetrahydro-2,4-dimethyl- (9CI) | | Synonyms: | 2-Furanacetaldehyde, 5-[(4E,6E,10Z,12E)-13-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-1,3,5,9,11-pentamethyl-2-oxo-4,6,10,12-tridecatetraenyl]tetrahydro-2,4-dimethyl- (9CI) | | CAS: | 183017-82-5 | | MF: | C32H46O5 | | MW: | 510.7 | | EINECS: | | | Product Categories: | | | Mol File: | 183017-82-5.mol | ![2-Furanacetaldehyde, 5-[(4E,6E,10Z,12E)-13-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-1,3,5,9,11-pentamethyl-2-oxo-4,6,10,12-tridecatetraenyl]tetrahydro-2,4-dimethyl- (9CI) Structure](CAS/20210305/GIF/183017-82-5.gif) |
| | 2-Furanacetaldehyde, 5-[(4E,6E,10Z,12E)-13-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-1,3,5,9,11-pentamethyl-2-oxo-4,6,10,12-tridecatetraenyl]tetrahydro-2,4-dimethyl- (9CI) Chemical Properties |
| Boiling point | 660.8±55.0 °C(Predicted) | | density | 1.029±0.06 g/cm3(Predicted) |
| | 2-Furanacetaldehyde, 5-[(4E,6E,10Z,12E)-13-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-1,3,5,9,11-pentamethyl-2-oxo-4,6,10,12-tridecatetraenyl]tetrahydro-2,4-dimethyl- (9CI) Usage And Synthesis |
| Uses | Leptofuranin C is found in the strain of Str. tanashiensis. Leptofuranin C causes the stagnation of normal cells, but it can cause the death of transformed cells[1]. | | References | [1] Y Hayakawa, et al. Studies on new antitumor antibiotics, leptofuranins A, B, C and D II. Physiocochemical properties and structure elucidation. J Antibiot (Tokyo). 1996 Oct;49(10):980-4. |
| | 2-Furanacetaldehyde, 5-[(4E,6E,10Z,12E)-13-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-1,3,5,9,11-pentamethyl-2-oxo-4,6,10,12-tridecatetraenyl]tetrahydro-2,4-dimethyl- (9CI) Preparation Products And Raw materials |
|
|
Tag:2-Furanacetaldehyde, 5-[(4E,6E,10Z,12E)-13-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-1,3,5,9,11-pentamethyl-2-oxo-4,6,10,12-tridecatetraenyl]tetrahydro-2,4-dimethyl- (9CI)(183017-82-5)
Related Product Information
|